Literature DB >> 8879071

Probability of developing or dying of cancer United States, 1991.

L Garfinkel.   

Abstract

Since the mid-1960s, the proportion of deaths from the leading cause of U.S. mortality, heart disease, has decreased fairly steadily. The proportion of cancer deaths has risen over the same period, however, from 16.3 percent in 1965 to 23.7 in 1991. Public awareness of this increase has resulted in questions being raised about the probability of developing or dying of cancer. Analyses of published data in the 1973-1991 Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute estimated a person's lifetime risk of developing or dying of cancer. The lifetime risk of developing cancer is 44.8 percent for men and 39.3 percent for women. For both sexes, the risk of dying of lung cancer is higher than for any other cancer.

Entities:  

Mesh:

Year:  1995        PMID: 8879071

Source DB:  PubMed          Journal:  Stat Bull Metrop Insur Co        ISSN: 0741-9767


  3 in total

1.  Temporal trends in the use of diagnostic imaging for inpatients with pancreatic conditions: How much ionizing radiation are we using?

Authors:  Alexsander K Bressan; Jean-Francois Ouellet; Divine Tanyingoh; Elijah Dixon; Gilaad G Kaplan; Sean C Grondin; Robert P Myers; Rachid Mohamed; Chad G Ball
Journal:  Can J Surg       Date:  2016-06       Impact factor: 2.089

2.  Radiation dose from computed tomography in patients with necrotizing pancreatitis: how much is too much?

Authors:  Chad G Ball; Camilo Correa-Gallego; Thomas J Howard; Nicholas J Zyromski; Michael G House; Henry A Pitt; Atilla Nakeeb; Christian M Schmidt; Fatih Akisik; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

Review 3.  Radiation dose from initial trauma assessment and resuscitation: review of the literature.

Authors:  Catherine M Hui; John H MacGregor; Homer C Tien; John B Kortbeek
Journal:  Can J Surg       Date:  2009-04       Impact factor: 2.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.